Stability of Prostacyclin in Human Plasma and Whole Blood: Studies on the Protective Effect of Albumin
- 1 January 1981
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 46 (03) , 645-647
- https://doi.org/10.1055/s-0038-1653438
Abstract
The biological half-life of prostacyclin in Krebs solution, human cell-free plasma or whole blood was measured by bracket assay on ADP-induced platelet aggregation. At 37°C, pH 7.4, plasma and blood reduced the rate of loss of antiaggregatory activity compared with Krebs solution. The protective effect of plasma was greater than that of whole blood. This effect could be partially mimicked by the addition of human or bovine serum albumin to the Krebs solution. The stabilisation afforded by human serum albumin was dependent on the fatty acid content of the albumin, although this was less important for bovine serum albumin.Keywords
This publication has 12 references indexed in Scilit:
- Albumins stabilize prostaglandin I2Prostaglandins, 1980
- Fatty acids bounds to serumalbumin decrease the half-life of thromboxane A2Prostaglandins, 1980
- Human platelet rich plasma and human serum protects from inactivation the antiaggregatory capacity of prostacyclin-like material (PGI2) produced by the rat stomach fundusProstaglandins, 1980
- Effects of intravenous infusion of prostacyclin (PGI2) in manProstaglandins, 1980
- Acid-catalysed hydrolysis of prostacyclin: origin of the unused labilityJournal of the Chemical Society, Chemical Communications, 1979
- Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesProstaglandins, 1978
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- The fatty acid content and drug binding characteristics of commercial albumin preparationsClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma.Journal of Clinical Investigation, 1976